Maryland

Medicaid Fee-for-Service released a bulletin updating its Brand vs Generic Preferred Drug List.  

Also in Maryland, the Prescription Drug Affordability Board's (PDAB's) Stakeholder Council will meet virtually on June 23 at 2:00 pm. The agenda and other meeting materials will be available on the Stakeholder Council page prior to the scheduled meeting. Registration is required to receive the meeting link.  

Finally in Maryland, the Prescription Drug Affordability Board also released an RFI to inform its cost review process for the drugs Skyrizi and Dupixet. Manufacturers, insurers, pharmacy benefit managers and wholesale distributors are eligible to respond.  

For more information, contact NACDS’ Jill McCormack at 717-592-8977.